Cheong-Kwan-Jang Korean HongSam Powder Capsule

Manufacturer: Korea Ginseng Corporation
Effective date: 2010-10-08
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: full-release
Hydrated at: 2026-05-31 22:27:00

Label at a glance#

ProductCheong-Kwan-Jang Korean HongSam

Active ingredientASIAN GINSENG

Label structure8 sections

Label contents#

Full prescribing information#

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient

Asian Ginseng USP 500mg

Purpose

OTC - PURPOSE SECTION

vitamin and mineral

Keep out of Reach of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Stop use and ask a doctor if

- chest pain, rapid heartbeat, or dizziness occurs
- your hands or feet swell
- breast tenderness
- menstrual irregularities

- If pregnant or breast feeding, ask a health professional before use.

- Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Indication & Usage

INDICATIONS & USAGE SECTION

Uses
- Supports immune system
- Improves the health of people recovering from illness.

Other information
- before use, read all information on carton and enclosed booklet.
- store at controlled room temperature 1 to 30 ℃
- do not store in hot location or expose to sunlight.

Warnings

WARNINGS SECTION

Allergy alert: Do not use if you have ever had a rash or other allergic reaction to Ginseng

Ask a doctor before use if you have
-heart disease
-high fever
-diabetes
-headaches and sleep problems
-gastrointestinal problems

Ask a doctor or pharmacist before use if you are taking antibiotics.

Dosage & Administraion

DOSAGE & ADMINISTRATION SECTION

Adults and children 15 years and older;
take 2 capsules with warm or cool water. 3 times daily.

Children under 15 years ;
take half dosage for adults

Inactive Ingredient

INACTIVE INGREDIENT SECTION

Hydroxypropyl Methylcellulose, Glacial acetic acid, Pectin, Purified Water, Glycerin, Calcium Gluconate, Sucrose Esters of fatty acids

Korea Ginseng Corporation

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Cheong-Kwan-Jang Korean HongSam Powder Capsule

Net WT. 3.17 OZ (90g) 180capsules

image of carton label

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
bee4fa8d-8d82-423a-a0b5-40a89dd13a99	Product name	1	20250618
48747306-602a-42cc-957b-5b0c69158eee	Product name	1	20180604
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51918-1001-3	2020-01-31	C162847	48780-1	9d75b9d1-0a80-f424-e053-dadaa90a57ce	Cheong-Kwan-Jang Korean HongSam Powder Capsule

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
51918-1001-3	Cheong-Kwan-Jang Korean HongSam	90000 mg in 1 BOX	CAPSULE	90000		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51918-1001	CHEONG-KWAN-JANG KOREAN HONGSAM (ASIAN GINSENG) CAPSULE [KOREA GINSENG CORPORATION]	2	Legacy NDC, 1 package rows	20110124_b7233ede-c7a1-43c9-b793-58929a380b2c.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ASIAN GINSENG	ACTIVE INGREDIENT	CUQ3A77YXI	2
ASIAN GINSENG	ACTIVE MOIETY	CUQ3A77YXI	2
ACETIC ACID	INACTIVE INGREDIENT	Q40Q9N063P	2
CALCIUM GLUCONATE	INACTIVE INGREDIENT	SQE6VB453K	2
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	2
HYPROMELLOSE 2208 (100 MPA.S)	INACTIVE INGREDIENT	B1QE5P712K	2
PECTIN	INACTIVE INGREDIENT	89NA02M4RX	2
SUCROSE	INACTIVE INGREDIENT	C151H8M554	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

Cheong-Kwan-Jang Korean HongSam
ASIAN GINSENG
ACETIC ACID
WATER
PECTIN
SUCROSE
GLYCERIN
CALCIUM GLUCONATE
HYPROMELLOSE 2208 (100 MPA.S)

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
51918-1001	51918-1001-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ASIAN GINSENG	CUQ3A77YXI	ACTIB
ACETIC ACID	Q40Q9N063P	IACT
WATER	059QF0KO0R	IACT
PECTIN	89NA02M4RX	IACT
SUCROSE	C151H8M554	IACT
GLYCERIN	PDC6A3C0OX	IACT
CALCIUM GLUCONATE	SQE6VB453K	IACT
HYPROMELLOSE 2208 (100 MPA.S)	B1QE5P712K	IACT

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 186 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCROSE	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
HYPROMELLOSE 2208 (100 MPA.S)	HYPROMELLOSE 2208 (100 MPA.S)	B1QE5P712K	POWDER, FOR SUSPENSION / ORAL		250 mg	Exact identifier — unii candidate 13 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SPRAY / NASAL	22.3 mg/1ml		Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	AEROSOL, FOAM / TOPICAL		21 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	CAPSULE / ORAL		3487 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	TABLET, FILM COATED / ORAL	1.55 mg		Exact identifier — unii candidate 75 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
HYPROMELLOSE 2208 (100 MPA.S)	HYPROMELLOSE 2208 (100 MPA.S)	B1QE5P712K	TABLET / BUCCAL		21 mg	Exact identifier — unii candidate 13 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SHAMPOO / TOPICAL	5 %w/w		Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	CREAM, AUGMENTED / TOPICAL		55 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
HYPROMELLOSE 2208 (100 MPA.S)	HYPROMELLOSE 2208 (100 MPA.S)	B1QE5P712K	INSERT / VAGINAL		16 mg	Exact identifier — unii candidate 13 equally ranked IID candidates
ACETIC ACID	ACETIC ACID	Q40Q9N063P	INJECTION / SOFT TISSUE	ADJ PH		Exact identifier — unii candidate 45 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	TABLET, CHEWABLE / ORAL		12 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	PASTE, DENTIFRICE / DENTAL	18 %w/w		Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	EMULSION / INTRAVENOUS	2.2 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	INJECTION / SUBCUTANEOUS		450 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
ACETIC ACID	ACETIC ACID	Q40Q9N063P	INJECTION, EMULSION / SUBCUTANEOUS	ADJ PH		Exact identifier — unii candidate 45 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	EMULSION / OPHTHALMIC		3 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	INJECTION, SOLUTION / SUBCUTANEOUS	15 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SOLUTION / AURICULAR (OTIC)	63.64 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	INJECTION / INTRAVENOUS		33750 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	CREAM / VAGINAL		60 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
ACETIC ACID	ACETIC ACID	Q40Q9N063P	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR	ADJ PH		Exact identifier — unii candidate 45 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	TABLET, COATED / ORAL	1 mg		Exact identifier — unii candidate 75 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	INJECTION / INTRADERMAL	1.6 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	FILM, EXTENDED RELEASE / TRANSDERMAL	306.2 mg		Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SOLUTION / DENTAL	15 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
ACETIC ACID	ACETIC ACID	Q40Q9N063P	SOLUTION / ORAL		10 mg	Exact identifier — unii candidate 45 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	INJECTION, SOLUTION / INTRAMUSCULAR	15 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
HYPROMELLOSE 2208 (100 MPA.S)	HYPROMELLOSE 2208 (100 MPA.S)	B1QE5P712K	LOTION / TOPICAL	0.1 %w/w		Exact identifier — unii candidate 13 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	AEROSOL / TOPICAL	3 %w/w		Exact identifier — unii candidate 75 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
HYPROMELLOSE 2208 (100 MPA.S)	HYPROMELLOSE 2208 (100 MPA.S)	B1QE5P712K	CAPSULE, EXTENDED RELEASE / ORAL		79 mg	Exact identifier — unii candidate 13 equally ranked IID candidates
ACETIC ACID	ACETIC ACID	Q40Q9N063P	SOLUTION / SUBCUTANEOUS	0.04 %w/v		Exact identifier — unii candidate 45 equally ranked IID candidates
ACETIC ACID	ACETIC ACID	Q40Q9N063P	INJECTION / INTRAMUSCULAR		22 mg	Exact identifier — unii candidate 45 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SYSTEM / IONTOPHORESIS	168.1 mg		Exact identifier — unii candidate 75 equally ranked IID candidates
ACETIC ACID	ACETIC ACID	Q40Q9N063P	LIQUID / SUBCUTANEOUS	0.2 %w/v		Exact identifier — unii candidate 45 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	CREAM / TOPICAL		1720 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SUPPOSITORY / RECTAL		440 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
ACETIC ACID	ACETIC ACID	Q40Q9N063P	INJECTION / INFILTRATION	NA		Exact identifier — unii candidate 45 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	SOLUTION / TOPICAL		1971 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
HYPROMELLOSE 2208 (100 MPA.S)	HYPROMELLOSE 2208 (100 MPA.S)	B1QE5P712K	SYRUP / ORAL		100 mg	Exact identifier — unii candidate 13 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
ACETIC ACID	ACETIC ACID	Q40Q9N063P	CREAM / VAGINAL	0.35 %w/w		Exact identifier — unii candidate 45 equally ranked IID candidates
ACETIC ACID	ACETIC ACID	Q40Q9N063P	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 45 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	GUM, CHEWING / BUCCAL		230 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
44f13ab9-0616-41f9-bd19-d0f75e8d558c			b7233ede-c7a1-43c9-b793-58929a380b2c	2010-10-08	Warnings	Exact identifier spl id: 44f13ab9-0616-41f9-bd19-d0f75e8d558c spl set id: b7233ede-c7a1-43c9-b793-58929a380b2c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.